B2B buyers evaluating MOTS-C as a sourcing project should confirm four items before comparing supplier quotes: exact sequence and CAS reference, salt form or counterion, purity method and threshold, and whether LC-MS data is available for identity review. Without these details, two quotes may look comparable while referring to different documentation scope, format, or batch-readiness.
This guide is written for overseas distributors, private label teams, OEM coordinators, formulation consultants, and procurement buyers preparing an RFQ for MOTS-C in bulk powder, lyophilized vial, or custom fill project formats.
The article helps buyers decide whether their RFQ is ready, what documents to request before comparing price, which red flags suggest a supplier is not ready for B2B projects, and what WUMO reviews before issuing a specification-backed quotation.
It is a B2B sourcing and specification reference. It does not provide end-user application guidance, biological-effect discussion, clinical recommendations, or outcome claims.
What Should Buyers Confirm First When Sourcing MOTS-C?
Buyers should first confirm whether the supplier can define MOTS-C by sequence, CAS reference, molecular weight, salt form, and analytical documentation. A product name alone is not enough for supplier qualification.
MOTS-C is commonly discussed as a 21-amino-acid synthetic peptide in research-grade sourcing contexts. Because longer peptide sequences can create more sourcing variables than short catalog peptides, buyers should check whether the supplier’s specification sheet, COA, HPLC report, LC-MS report where available, label, and packing information all refer to the same material definition.
Common sourcing identifiers may include:
- Product name: MOTS-C.
- CAS number commonly referenced in supplier contexts: 1627580-64-6.
- Molecular formula commonly referenced: C100H172N34O29.
- Molecular weight commonly referenced: approximately 2174.7 Da.
- Sequence reference: should be confirmed in the supplier specification sheet.
- Physical form: commonly supplied as white to off-white lyophilized powder.
- Common B2B formats: bulk powder and lyophilized vial.
Every identifier should be verified against supplier documentation. If a supplier cannot provide a specification sheet that defines the exact material being quoted, the buyer should not treat the quotation as ready for final comparison.
Why Do MOTS-C Sourcing Projects Stall?
MOTS-C sourcing projects usually stall when buyers compare price before confirming specification, salt form, LC-MS availability, MOQ basis, and documentation scope. The result is a quote comparison that looks organized but is built on mismatched assumptions.
Common reasons MOTS-C sourcing projects stall include:
- Salt form or counterion is not disclosed.
- LC-MS availability is not clarified before quotation.
- Purity threshold is not defined by the buyer.
- USD/g and USD/vial quotes are compared without normalization.
- MOQ is stated without batch basis.
- Custom vial projects begin before fill amount is confirmed.
- Storage and shipment requirements are not discussed before freight planning.
- Documentation gaps are discovered only after quotation.
A stronger RFQ should define the product, format, documentation expectations, MOQ range, quote unit, and destination-market shipment context before the supplier responds. That reduces back-and-forth and gives the buyer a cleaner basis for supplier comparison.
For quote unit review, see WUMO’s guide: Peptide Quote Units Explained: USD/g vs USD/vial vs USD/box.
What Specification Fields Should Every MOTS-C Buyer Review?
Before issuing an RFQ for MOTS-C, buyers should review ten core specification fields: product name, CAS reference, sequence, molecular formula, molecular weight, purity method, salt form, appearance, storage condition, and retest or shelf-life statement. Missing fields create downstream comparison and documentation risk.
| Specification Field | What Buyers Should Confirm |
|---|---|
| Product name | MOTS-C, with consistent naming across all documents |
| CAS reference | Confirm supplier specification uses the expected CAS reference |
| Sequence reference | Confirm exact amino acid sequence or supplier sequence standard |
| Molecular formula | Confirm formula matches supplier COA and specification sheet |
| Molecular weight | Confirm theoretical mass and observed mass where LC-MS is available |
| Purity | Confirm HPLC area% and required threshold before quotation |
| Salt form / counterion | Confirm acetate, TFA, or other form if relevant |
| Appearance | White to off-white lyophilized powder or supplier-defined standard |
| Storage condition | Confirm temperature, moisture, and light-protection requirements |
| Shelf life / retest date | Confirm lot-specific or supplier-standard statement |
The specification sheet should be reviewed before the COA whenever possible. The specification sheet defines what the supplier intends to provide; the COA reports the result for a specific lot or batch.
If the specification sheet does not state salt form, sequence reference, or analytical method, the buyer should request clarification before price comparison.
What Documents Should Buyers Request Before Comparing MOTS-C Quotes?
Buyers should request five core documents before comparing MOTS-C supplier quotes: COA, HPLC report, LC-MS report where available, SDS, and specification sheet. Each document verifies a different part of supplier qualification.
| Document | What It Confirms | When to Request | Why It Matters for MOTS-C |
|---|---|---|---|
| COA | Lot identity, purity, appearance, test results | Qualification stage | Confirms batch-linked quality data |
| HPLC report | Purity by chromatographic method | With COA | Shows method support behind purity value |
| LC-MS report | Molecular weight and identity support | Before final supplier comparison where available | Helps review sequence-sensitive sourcing |
| SDS | Handling, storage, and transport information | Before shipment discussion | Supports logistics and internal safety review |
| Specification sheet | Supplier’s product standard | Before quote comparison | Defines what the supplier is actually offering |
A COA alone is not enough for a complete sourcing decision. A COA may show a purity value, but buyers still need the HPLC report to understand method support and the specification sheet to understand what the batch is measured against.
LC-MS is especially important when the buyer needs stronger identity review. If the supplier cannot provide LC-MS by default, the buyer should ask whether it can be provided on request, whether it is batch-specific or representative, and whether it affects lead time or cost.
Documentation supports sourcing review. It does not guarantee import clearance, registration, sale permission, or approval in any destination market.
What Red Flags Suggest a MOTS-C Supplier Is Not Ready for B2B Projects?
The most serious red flags in MOTS-C sourcing are missing LC-MS availability, undisclosed salt form, purity claims without HPLC support, and specification sheets that do not define the material being quoted. These issues make quote comparison unreliable.
| Red Flag | Why It Matters | Buyer Action |
|---|---|---|
| No LC-MS data available or no explanation of availability | Identity review is incomplete for a sequence-sensitive project | Request availability, scope, and batch linkage |
| Salt form not disclosed | Fill weight and content comparison may be unreliable | Require clarification before comparing price |
| Purity claimed without HPLC report | Purity value cannot be reviewed properly | Request chromatogram and method details |
| Specification sheet unavailable | No baseline for quote comparison | Treat supplier as not yet qualified |
| COA references different naming or sequence | Possible specification mismatch | Stop and re-confirm product identity |
| MOQ stated verbally only | No written batch basis | Request written MOQ and tier structure |
| Lead time given without stock or production basis | Project timeline may be unreliable | Confirm stage-by-stage lead time |
| No SDS at inquiry stage | Shipment planning cannot proceed | Request SDS before freight discussion |
| Auto-quote issued without specification review | Supplier may not be evaluating project fit | Ask for specification-backed quotation |
A red flag does not always disqualify a supplier. It means the buyer should pause and request clarification before paying a deposit, approving a sample, or issuing a purchase order.
Should Buyers Choose Bulk Powder or Lyophilized Vial Format for MOTS-C?
The right MOTS-C format depends on the buyer’s downstream operation. Bulk powder is better suited for buyers that require further processing or repackaging; lyophilized vial format is better suited for projects that need a defined vial-based commercial or channel-ready unit.
| Factor | Bulk Powder | Lyophilized Vial |
|---|---|---|
| Typical buyer | Distributor, formulator, repackager | Private label, OEM, distribution-ready project |
| Quote unit | USD/g or USD/mg | USD/vial or USD/box |
| MOQ basis | Gram quantity or batch size | Vial count, box count, or fill batch |
| Key specification issue | Purity, salt form, packaging weight | Fill amount, vial size, stopper, label |
| Lead time | Shorter if stock exists | Longer due to fill-and-finish steps |
| Documentation | COA, HPLC, LC-MS, SDS, specification sheet | Core documents plus fill and packaging details |
| Custom options | Container size, packaging format | Fill amount, vial configuration, label format |
| Shipment planning | Storage and packaging requirements | Storage, vial packaging, box format, freight planning |
A USD/g quote for bulk powder cannot be directly compared with a USD/vial quote for finished vials. Buyers should separate peptide material cost, fill service, packaging, documentation, and shipment scope before deciding which format is more suitable.
For broader vial project scoping, see WUMO’s lyophilized peptide vial sourcing guide.
What Do MOQ and Lead Time Actually Mean for a MOTS-C Project?
For MOTS-C, MOQ and lead time depend on format, batch status, documentation scope, and whether the project requires custom filling or private label packaging. Buyers should confirm both in writing at the inquiry stage.
| Scenario | MOQ Basis | Lead Time Factor | Key Confirmation |
|---|---|---|---|
| Bulk powder, in stock | Per gram or available lot | Shorter | Confirm stock quantity and retest date |
| Bulk powder, production required | Minimum batch size | Longer | Confirm production schedule and QC timeline |
| Standard lyophilized vial | Vial count or batch minimum | Moderate to long | Confirm fill schedule availability |
| Custom fill, standard label | Batch minimum | Long | Confirm fill amount and vial configuration first |
| Custom fill, private label | Batch minimum plus packaging scope | Longest | Confirm label artwork and approval timing |
A single lead time number is rarely enough. Buyers should ask whether the stated timeline includes material availability, production, QC testing, documentation preparation, vial filling, packaging, export preparation, and dispatch.
Freight transit time is separate from production lead time. Buyers should not treat supplier production lead time as delivered lead time.
For broader MOQ and project scale review, see WUMO’s bulk peptide purchasing guide.
How Should Buyers Prepare a Stronger RFQ for MOTS-C?
A stronger MOTS-C RFQ should define product identity, sequence reference, salt form, purity threshold, format, fill amount, documentation scope, MOQ range, destination, and timeline before the supplier responds. Without these fields, suppliers may quote against different assumptions.
| RFQ Field | Why It Matters |
|---|---|
| Product name and CAS reference | Prevents specification mismatch |
| Sequence reference | Confirms the peptide identity being quoted |
| Salt form preference | Affects content and fill-weight comparison |
| Purity threshold and method | Enables comparable quote review |
| Format | Determines MOQ, quote unit, and lead time |
| Fill amount if vials are requested | Required for USD/vial comparison |
| Required documents | Sets expectations for COA, HPLC, LC-MS, SDS, specification sheet |
| Target MOQ range | Filters out mismatched suppliers |
| Destination country or region | Supports SDS, label, and freight planning |
| Project timeline | Helps supplier judge feasibility |
| Packaging or label scope | Required for private label or custom vial projects |
| Quote unit preference | Avoids USD/g vs USD/vial mismatch |
A weak RFQ asks only for product name, quantity, and price. A stronger RFQ gives the supplier enough structure to issue a specification-backed quotation.
What Supplier Qualification Checkpoints Apply to MOTS-C Projects?
A qualified MOTS-C supplier should be able to confirm product identity, disclose salt form, provide documentation scope, explain MOQ basis, and review the buyer’s project requirements before issuing a formal quotation. Auto-quoting without specification review is a weak signal for B2B procurement.
Supplier qualification checkpoints include:
- Supplier confirms product name, CAS reference, and sequence reference.
- Specification sheet is available before formal quotation.
- LC-MS or mass confirmation is available where requested.
- HPLC purity method is documented with chromatographic details.
- Salt form or counterion is disclosed in specification sheet.
- SDS is available at inquiry stage.
- Batch number links to COA and test records.
- Lead time is stated with stock vs. production basis.
- MOQ is confirmed in writing with batch basis explained.
- Supplier reviews buyer specification before quoting.
- Custom fill or private label capability is confirmed if required.
For a broader supplier review framework, see WUMO’s peptide supplier qualification checklist.
What Does WUMO Review Before Issuing a Formal MOTS-C Quotation?
WUMO reviews five areas before issuing a formal quotation for MOTS-C: specification alignment, documentation availability, MOQ feasibility, quote unit basis, and project fit. A useful quotation starts with product definition, not an automatic price.
WUMO may review:
- Product name, CAS reference, and sequence reference.
- Salt form or counterion.
- Bulk powder vs. lyophilized vial format.
- Target quantity and quote unit.
- Fill amount if vial format is requested.
- Documentation scope: COA, HPLC, LC-MS, SDS, specification sheet.
- Batch traceability requirements.
- MOQ and lead time expectations.
- Packaging and label scope.
- Destination-market shipment considerations.
- Whether NDA is needed before custom project discussion.
This review helps avoid quoting the wrong format, wrong unit, wrong documentation scope, or unrealistic MOQ.
How Does WUMO Support Qualified MOTS-C B2B Sourcing Projects?
WUMO supports qualified B2B buyers with MOTS-C sourcing discussion, specification review, documentation review, and project quotation support. The process is designed for distributors, OEM teams, private label buyers, and sourcing consultants preparing structured RFQs.
For MOTS-C projects, WUMO can help buyers clarify:
- Bulk powder or lyophilized vial format.
- Product identity and sequence reference.
- Documentation scope.
- COA, HPLC, LC-MS, SDS, and specification sheet availability.
- MOQ and volume tier discussion.
- Lead time assumptions.
- Quote basis.
- Custom fill feasibility.
- Neutral label or private label discussion.
- Packaging scope.
- Project fit before formal quotation.
Availability may vary by batch, project type, destination requirement, and buyer specification. Buyers are encouraged to state product definition, format, documentation, MOQ, and packaging requirements before quotation so the project can be reviewed properly.
Frequently Asked Questions
What is the CAS number for MOTS-C and how do I confirm it with a supplier?
MOTS-C is commonly referenced in supplier contexts with CAS number 1627580-64-6. Buyers should confirm the CAS reference in the supplier’s specification sheet and check that the same product identity appears on the COA, HPLC report, LC-MS report where available, and label.
What is the molecular weight of MOTS-C and why does LC-MS verification matter?
MOTS-C is commonly referenced with a molecular weight of approximately 2174.7 Da. LC-MS helps confirm whether the observed mass aligns with the expected sequence reference, which is important when buyers are comparing suppliers for a longer peptide sourcing project.
What salt form does MOTS-C typically come in, and does it affect fill weight calculation?
Suppliers may quote different salt forms or counterions, so buyers should confirm the exact form in the specification sheet and COA. Salt form can affect molecular weight reference, peptide-content basis, and fill-weight calculation in lyophilized vial projects.
What documentation should I request before issuing an RFQ for MOTS-C?
Buyers should request or confirm the availability of COA, HPLC report, LC-MS report where available, SDS, and specification sheet before serious quote comparison. These documents help define product identity, purity method, batch traceability, storage, and shipment readiness.
Why is LC-MS particularly important for MOTS-C compared with shorter peptides?
LC-MS is useful for reviewing whether the observed mass aligns with the expected sequence reference. Longer peptide sequences can create more sourcing and verification variables, so buyers should clarify whether LC-MS is available before relying on price alone.
What purity threshold should I specify for a MOTS-C sourcing project?
The required purity threshold depends on the buyer’s project specification. Buyers should define the threshold before quotation and confirm that the supplier can support it with HPLC data and batch-linked documentation.
What is the typical MOQ for MOTS-C in bulk powder vs. lyophilized vial format?
MOQ varies by supplier, product form, fill amount, packaging scope, and whether the material is in stock or produced to order. Buyers should request volume tiers and clarify whether MOQ is based on grams, vials, boxes, or batch size.
What lead time should I expect for a MOTS-C custom fill vial project?
Lead time depends on material availability, fill amount, vial format, QC testing, documentation preparation, packaging, and export planning. Buyers should ask for a stage-by-stage lead time rather than relying on one total number.
What are the most common red flags when evaluating MOTS-C suppliers?
Common red flags include missing LC-MS availability, salt form not disclosed, COA without batch number, purity claim without HPLC report, unclear MOQ basis, lead time without scope, and documentation available only after payment.
How should I structure an RFQ for a MOTS-C lyophilized vial private label project?
A strong RFQ should include product name, CAS reference, sequence reference, salt form, purity threshold, fill amount per vial, vial count or box format, documentation requirements, packaging scope, destination country, and quote unit preference.
What storage and shipment conditions apply to MOTS-C bulk powder and vials?
Storage and shipment conditions should be confirmed from the supplier’s specification sheet, label, SDS, and shipment documentation. Buyers should avoid assuming one universal condition and should confirm batch-specific or supplier-standard requirements before dispatch.
Does a COA and HPLC report guarantee import clearance for MOTS-C?
No. COA and HPLC documents support sourcing review, but they do not guarantee import clearance, regulatory approval, sale permission, or downstream compliance in any destination market. Buyers remain responsible for destination-market requirements.
What is the difference between USD/g and USD/vial quote basis for MOTS-C?
USD/g usually refers to bulk powder material cost, while USD/vial includes fill amount and may include vialing, packaging, and other project services. Buyers should normalize quotes to peptide-content basis and review service scope separately.
How does WUMO review a MOTS-C sourcing project before issuing a quotation?
WUMO reviews product definition, sequence reference, salt form, documentation scope, MOQ feasibility, quote unit, format, and project fit before issuing a quotation. This helps avoid quoting the wrong material definition, format, or documentation scope.
CTA
If you are evaluating MOTS-C as a B2B sourcing project, WUMO can review your specification, confirm available documentation, and discuss format options, MOQ, and project fit before issuing a formal quotation.
Qualified B2B buyers are welcome to submit a project inquiry with product definition, preferred format, quantity, quote unit, and documentation requirements.